EDGAR Filing Documents for 0001571049-17-002519

Form 8-K - Current report:

SEC Accession No. 0001571049-17-002519

Filing Date

2017-03-17

Accepted

2017-03-17 06:05:49

Documents

Period of Report

2017-03-16

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	t1700770_8k.htm	8-K	53436
2	EXHIBIT 2.1	t1700770_ex2-1.htm	EX-2.1	577741
3	EXHIBIT 10.1	t1700770_ex10-1.htm	EX-10.1	66790
4	EXHIBIT 10.2	t1700770_ex10-2.htm	EX-10.2	66218
5	EXHIBIT 99.1	t1700770_ex99-1.htm	EX-99.1	68491
6	EXHIBIT 99.2	t1700770_ex99-2.htm	EX-99.2	16458
	Complete submission text file	0001571049-17-002519.txt		850778

Mailing Address 106 ALLEN ROAD FOURTH FLOOR BASKING RIDGE NJ 07920

Business Address 106 ALLEN ROAD FOURTH FLOOR BASKING RIDGE NJ 07920 908-842-0100

Caladrius Biosciences, Inc. (Filer) CIK: 0000320017 (see all company filings)